Topic
immune disease
12 stories related to this topic, newest first.
news.sky.comai27 days ago
Cambridge firm uses AI to revive failed drugs
A UK company founded in 2021 applies artificial-intelligence models to identify why certain drugs failed clinical trials and to redesign them for renewed testing. The firm has raised US$6.9 million and built a pipeline focused on autoimmune diseases and blood cancers.
NA
New York Postworld54 days ago
UCLA Rower Manages Rare Neurological Disorder While Competing
UCLA rower Claire Prindiville continues to train and compete after being diagnosed with a rare autoimmune disease that affects the central nervous system. She has described maintaining a daily routine that includes early training and monitoring symptoms.
Statscience56 days ago
FDA Approves BeOne Medicines’ Beqalzi for Relapsed/Refractory Mantle Cell Lymphoma
BeOne Medicines received FDA approval for its BCL-2 inhibitor Beqalzi to treat relapsed or refractory mantle cell lymphoma. The drug is the first BCL-2 inhibitor specifically cleared for this indication in the U.S. Separately, CREATE Medicines raised $122 million to advance its i…
rte.iescience56 days ago
CREATE Medicines Raises $122 Million to Advance CAR-T Candidates Into Human Trials
The biotechnology company, formerly known as Myeloid Therapeutics, secured the funding from Newpath Partners, ARCH Venture Partners and Hatteras Venture Partners. CREATE Medicines, cofounded by Siddhartha Mukherjee, is developing CAR-T therapies using myeloid cells to target soli…
Substrate placeholder — needs reviewscience82 days ago
Study Finds Elevated Copper Levels in Regulatory T Cells of Rheumatoid Arthritis Patients
A recent study has identified increased copper levels in regulatory T cells among patients with rheumatoid arthritis. This finding may inform the development of new treatments for autoimmune diseases. The research highlights potential therapeutic avenues based on these observatio…
SC
Substrate placeholder — needs reviewscience88 days ago
Woman with Rare Combination of Three Autoimmune Diseases Reports No Symptoms After Engineered Immune Cell Treatment
A woman diagnosed with an ultra-rare combination of three autoimmune diseases received a single dose of engineered immune cells. She has experienced no symptoms since the treatment. The case was reported in a medical journal.
NA
medpagetoday.comscience90 days ago
Recent Developments in CAR-T Therapy for Autoimmunity and GSK's Discontinuation of Leucovorin
Researchers are exploring CAR-T cell therapy's potential in treating autoimmune diseases beyond cancer. GlaxoSmithKline announced it will discontinue leucovorin, a drug used in chemotherapy support. These updates highlight ongoing advancements and changes in the biotechnology sec…
ST
Substrate placeholder — needs reviewscience90 days ago
Study Reveals Sex Differences in Immune Cell Aging from Analysis of About 1,000 People
Researchers conducted single-cell analysis on approximately 1,000 individuals and found substantial differences in how immune cells age between sexes. The study, published in Nature Aging, links these differences to variations in autoimmune disease rates in women and cancer vulne…
ER
Substrate placeholder — needs reviewscience90 days ago
Woman with Three Autoimmune Diseases Achieves Remission After CAR-T Cell Therapy in Germany
A 47-year-old woman with severe autoimmune hemolytic anemia, immune thrombocytopenia, and antiphospholipid antibody syndrome received CAR-T cell therapy at University Hospital Erlangen in Germany last year. The treatment, which targets CD19 on B-cells, led to remission within wee…
Substrate placeholder — needs reviewscience91 days ago
CAR-T Therapy Shows Increasing Remissions in Autoimmune Diseases with Rising Experimentation and Investment
CAR-T cell therapy, originally developed for cancer treatment, is achieving more remissions in patients with autoimmune diseases. According to STAT News, this progress has prompted additional clinical trials and investments from pharmaceutical companies.
ST
Adrian McArdle, M.B, B.Ch., Kshemendra Senarath-Yapa, M.B.B.Chir., Graham G. Walmsley, B.S., Michael Hu, M.D., M.P.H., David A. Atashroo, M.D.,Ruth Tevlin, M.B., B.Ch.,Elizabeth Zielins, M.D.,Geoffrey C. Gurtner, M.D., Derrick C. Wan, M.D., and Michael T. Longaker, M.D., F.A.C.S. / Wikimedia (CC BY-SA 4.0)science91 days ago
Researchers Report B Cell Rebooting Success in Additional Autoimmune Diseases
A study has demonstrated the effectiveness of B cell rebooting in treating myasthenia gravis and other autoimmune conditions. The approach, previously tested in lupus and multiple sclerosis, involves depleting and resetting B cells. @EricTopol reported on the findings, highlighti…
ER
Substrate placeholder — needs reviewworld91 days ago
Researchers Report CAR-T Cell Therapy Success in Severe Autoimmune Disease Case
A 47-year-old woman with three severe autoimmune diseases received experimental CAR-T cell therapy in early 2025 after nine failed treatments. The therapy, originally developed for cancer, targets problematic immune cells to induce remission. The patient has since returned to nor…